While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

A new study suggests that heavy cannabis use may impair working memory, even after someone has stopped using it.

Monument Releasing has acquired North American rights to The Fishbowl, a Puerto Rican film that debuted at Sundance.

University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

With proper guidance and usage, medical cannabis in India may offer a valuable addition to your stress management toolkit, ...

A new study shows Minnesota's medical cannabis program has yielded meaningful results in pain reduction amongst patients.

All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.

After months of anticipation, Kentucky has issued its first medical marijuana cards to qualifying patients in the state, with ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.